Comerica Bank Mersana Therapeutics, Inc. Transaction History

Comerica Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 22, 2021	SELL	$8.56 - $14.47 $1.26 Million - $2.13 Million	-147,312 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$13.28 - $18.07 $717,996 - $976,972	54,066 Added 57.98%	147,312 $2 Million
Q1 2021 Apr 28, 2021	BUY	$15.31 - $26.52 $1.43 Million - $2.47 Million	93,246 New	93,246 $1.51 Million

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.